Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

First-year students encouraged to attend UFS welcoming function
2007-01-12

Main Campus, Bloemfontein
The University of the Free State (UFS) will host a welcoming function for all new first-year students and their parents on Saturday 13 January 2007 in the Callie Human Centre on the Main Campus in Bloemfontein.
 
The function starts at 11:00 and will be addressed by the Rector and Vice-Chancellor of the UFS, Prof Frederick Fourie. UFS staff will also be available to provide vital information to first-year students on academic matters.
 
Saturday’s welcoming function can assist students and parents by providing vital information on the registration process, which starts on Tuesday 16 January 2007, and the many high quality academic learning programmes on offer in six faculties at the UFS.
 
The UFS has split the registration process into various categories of students and students should adhere to the dates, and times which apply to them as a one-stop service will be available so as to avoid unnecessary delays in the registration process.
 
The registration of first-time entering first-year students who applied before 30 November 2006 to study at the Bloemfontein Campus will take place from Tuesday 16 January 2007 at the Callie Human Centre.
 
Senior undergraduate students (that is, students entering their second or later year of study) may register from 22 January 2007 according to a programme that was sent to all students who were registered at the UFS in 2006.
 
Postgraduate students, first-time entering first-year students and other students, who applied for admission to the Main Campus after 30 November 2006 and were accepted, must register at the Callie Human from 5 February 2007. 
 
Late applications will be accepted until Monday 15 January 2007 at the Information Centre on the Main Campus’ Thakaneng Bridge. 
 
Lectures will commence on 5 February 2007 and the registration process will end on 9 February 2007.
 
Vista Campus:
The Vista Campus in Bloemfontein – which was incorporated into the UFS in January 2004 – no longer accepts applications from first-year students. Such prospective students had to apply to the UFS Main Campus. Students who had been registered on the Vista Campus last year must register at the Vista Campus on the same dates as applicable on the Main Campus.
 
Qwaqwa Campus:
At the Qwaqwa Campus of the UFS all first-time entering first-year students must report on Sunday 14 January 2007 for orientation, after which the registration of these students will take place according to a specific programme as from Wednesday 17 January 2007. The official welcoming functioning for new first-years at the Qwaqwa Campus of the UFS will take place on Saturday 10 February 2007 at 08:00 in the Rolihlahla Mandela Hall on the Qwaqwa Campus.
 
First-year students who have applied to study at the Qwaqwa Campus and their parents should attend this function which fulfils the same role as the one held on the Bloemfontein Main Campus.
 
Detailed information on the dates and times of registration for the various faculties and academic learning programmes is available on the UFS website at www.ufs.ac.za
 
Prospective students may also call the Main Campus in Bloemfontein on 051 4013000 or the Qwaqwa Campus on 058 718-5000 for more information.
 
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
11 January 2007
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept